Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Comb Chem High Throughput Screen ; 25(11): 1966-1972, 2022.
Article in English | MEDLINE | ID: mdl-34610782

ABSTRACT

BACKGROUND: Phencyclidine (PCP, I) and its substituted analogs are significant and broadly abused psychotomimetic drugs that affect the central nervous system. They possess many pharmacological properties due to the presence of specific receptors in the brain. AIMS AND OBJECTIVE: Methyl group, despite strong electron-donating and characters of dipole moments, was placed on various positions of phenyl and amine moieties of phencyclidine along with the substitution of benzylamine, piperazine, and aniline derivatives in place of piperidine ring of phencyclidine to create novel compounds of the core with analgesic properties. MATERIALS AND METHODS: For evaluation of the analgesic activities of newly synthesized compounds, they were screened by tests of tail immersion (thermal) and formalin (chemical) pains. The obtained data with the control and PCP groups were also compared. RESULTS: The outcomes indicated that some new compounds have more antinociceptive effects than PCP in tail immersion and formalin tests. In the tail immersion test, the methyl piperazine analog (III) shows more efficacy than others. In the formalin test, none of the compounds are as effective as phencyclidine at the earliest time-point, but compounds IV and V show effectiveness during the second stage of formalin pain. CONCLUSION: It can be concluded that the methyl-piperazine analog of phencyclidine was the best candidate to decrease acute thermal pain, and benzylamine derivatives were suitable candidates to reduce chemical pains.


Subject(s)
Amines , Phencyclidine , Amines/pharmacology , Analgesics/chemistry , Analgesics/pharmacology , Aniline Compounds/therapeutic use , Animals , Benzylamines , Formaldehyde , Mice , Pain/drug therapy , Phencyclidine/pharmacology , Piperazines
2.
Mikrochim Acta ; 187(10): 548, 2020 09 04.
Article in English | MEDLINE | ID: mdl-32886213

ABSTRACT

For the first time, a fiber coating based on copper metal-organic framework was fabricated on an anodized stainless steel wire by an in situ electrosynthesis approach. The fiber was used for the preconcentration and determination of methamphetamine by headspace solid-phase microextraction followed by gas chromatography-flame ionization detection. The electrosynthesis of the fiber coating was performed under a constant potential of - 1.7 V by controlling the electrogeneration of OH- in a solution containing sodium nitrate as the probase, 1,2,4,5-benzenetetracarboxylate acid as the ligand and copper nitrate as the cation source. The coating was characterized using field emission scanning electron microscopy, energy-dispersive X-ray spectroscopy, Fourier transform infrared spectroscopy, and thermogravimetric analysis. The effective parameters on the electrosynthesis, extraction, and desorption processes were thoroughly optimized. Under the optimized conditions, metamphetamine (MAP) was quantified over a linear range of 0.90-1000.0 ng mL-1 with R2 > 0.997. A limit of detection of 0.1 ng mL-1 was achieved, and intra- and inter-day relative standard deviations were found within the range 3.0-4.4% and 2.8-3.9%, respectively. Finally, the method was successfully applied to determination of MAP in urine samples with good recoveries in the range 85.0-102.5%. Graphical abstract Schematic representation of the in-situ electrochemical synthesis of a Cu-based metal-organic framework and its application in a headspace SPME procedure for the measuring methamphetamine in urine samples followed by GC-MS analysis.


Subject(s)
Copper/chemistry , Electrochemistry/methods , Gas Chromatography-Mass Spectrometry/methods , Metal-Organic Frameworks/chemistry , Methamphetamine/urine , Solid Phase Microextraction/methods , Humans , Methamphetamine/chemistry
3.
Comb Chem High Throughput Screen ; 22(8): 570-576, 2019.
Article in English | MEDLINE | ID: mdl-31622215

ABSTRACT

BACKGROUND: Phencyclidine (PCP, I) is a synthetic drug with remarkable physiological properties. PCP and its analogues exert many pharmacological activities and interact with some neurotransmitter systems in the central nervous system like particular affinity for PCP sites in NMDA receptors or dopamine uptake blocking or even both. AIM AND OBJECTIVE: The following research, methyl group with electron-donating and dipole moment characters was added in different positions of phenyl ring along with the substitution of benzylamine (with many pharmacological effects) instead of piperidine ring of I to produce new compounds (II-V) of this family with more analgesic activities. MATERIALS AND METHODS: Analgesic activities of these new compounds were measured by tail immersion and formalin tests for acute and chronic pains, respectively. Also, the outcomes were compared with control and PCP (10 mg/kg) groups. RESULTS: The results indicate that compounds III, IV, and V have more acute and chronic antinociceptive effects than PCP and compound II which may be concerned with more antagonizing activities of these new painkillers for the blockage of dopamine reuptake as well as high affinity for NMDA receptors PCP binding site. CONCLUSION: It can be concluded that the benzylamine derivative of phencyclidine with a methyl group on the benzyl position on phenyl ring (V) is a more appropriate candidate to reduce acute and chronic (thermal and chemical) pains compared to other substituted phenyl analogs (II-IV) and PCP.


Subject(s)
Amines/analysis , Pain/diagnosis , Phencyclidine/analysis , Amines/chemical synthesis , Animals , Formaldehyde/administration & dosage , High-Throughput Screening Assays , Male , Mice , Mice, Inbred Strains , Molecular Structure , Pain/chemically induced , Pain Measurement , Phencyclidine/chemical synthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...